Home Health Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced...

Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial – The Lancet

5
0
SHARE



Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial The Lancet

Nintedanib targets VEGF receptors 1–3, PDGF receptors α and β, FGF receptors 1–3, and Src and Abl kinases, which are all implicated in malignant pleural …



Source : https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(19)30139-0/fulltext

News Feed From news.google.com